SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares surged after reporting positive Phase 3 results for a personalized mRNA skin cancer vaccine, sparking a massive short squeeze and intense speculation about the stock's future potential. While bulls are celebrating the validation of the mRNA oncology platform, skeptics are actively debating the high valuation and the risks of a sharp retracement, with many investors closely monitoring for potential equity offerings.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is seeing a surge in bullish sentiment and aggressive buying pressure, fueled by reports of a high-profile crypto summit, U.S. government discussions around holding digital assets, and broader liquidity injections that have triggered a massive short squeeze. The community is actively debating the sustainability of this momentum, with bulls pointing to the end of a long-term technical bear cycle, while skeptics warn of potential volatility and historical cycle patterns that historically favor late-year accumulation.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is rallying ahead of its earnings call as the community reacts to record fiscal Q2 results, strong user growth, and the positive impact of the PDT rule elimination. Investors are actively debating whether the stock's recent momentum and strong revenue performance will trigger a significant short squeeze or if the current price levels remain undervalued compared to industry peers.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is generating significant community conversation as investors focus on its potential role as a foundational settlement layer for institutional real-world asset tokenization. Despite ongoing price volatility, traders are actively debating its technical infrastructure, upcoming network upgrades, and potential long-term benefits from staking as they look for signs of a sustained trend reversal.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is drawing significant attention as traders bet on a broader crypto rally, with the community actively debating whether recent price action marks the start of a sustainable bull cycle. Investors are closely watching for a breakout past key resistance levels, fueled by optimism surrounding regulatory clarity and increased institutional interest in the broader ecosystem.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies Inc. is trending as investors discuss its strong connection to the Hyperliquid ecosystem and the potential for a gamma squeeze fueled by high short interest and institutional accumulation. Community members are actively debating the company's valuation, its treasury strategy, and the excitement surrounding its inclusion in upcoming index rebalancing.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is drawing significant investor interest as community members speculate on a potential take-private bid by activist investors, fueling intense debate regarding a possible short squeeze. Bulls are highlighting high short interest and institutional accumulation as indicators of a pending breakout, while bears express skepticism about the company's valuation and the reality of the buyout rumors.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is surging following positive Phase 3 clinical trial results for its avexitide treatment in patients with post-bariatric hypoglycemia, which triggered a wave of analyst price target upgrades. The company further fueled market activity by announcing a significant common stock offering to fund future pre-commercialization and development efforts, sparking intense community debate among investors weighing the strong clinical data against potential near-term dilution risks.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing heightened trading activity as the community remains deeply polarized, with intense debate centered on the company's financial stability, ongoing political controversies, and the broader implications of recent executive-level decisions. Discussions are dominated by fierce clashes between supporters and critics regarding the stock's valuation, market influence, and the impact of the current administration's policies on the platform's long-term viability.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is seeing significant volatility as market participants weigh a security vulnerability in its VMware software against concerns over the massive scale of AI-related debt financing vehicles. Despite the recent price decline, the community remains heavily divided between those viewing the pullback as an institutional-led liquidity sweep for an attractive entry point and others wary of the stock's recent performance relative to other semiconductor peers.

statis crypto Watchlist

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lucid Diagnostics Could Be 'High In The Queue' For Medicare Coverage Decision, Analyst Says

Lucid Diagnostics confirmed its first LBM win with Concert, opens up 10M covered lives. Analyst maintains Buy rating and $2.50 PT.read more...

PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results

PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results PR Newswire NEW YORK, Aug. 14, 2026 Veris Health accelerated its commercial engagement with OSU-The JamesVeris Health implantable...

Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue Estimates

Lucid Diagnostics (LUCD) delivered earnings and revenue surprises of -50.00% and -1.73%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results PR Newswire NEW YORK, Aug. 13, 2026 Recognized 2Q26 revenue of $1.5 millionProcessed 2,770 EsoGuard testsSecured...

Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of +54.55% and +3.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Pulse Biosciences, Inc (PLSE) Reports Q2 Loss, Misses Revenue Estimates

Pulse Biosciences (PLSE) delivered earnings and revenue surprises of -16.13% and -38.00%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard Esophageal DNA Test

Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard Esophageal DNA Test Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard Esophageal DNA Test PR Newswire NEW YORK, Aug. 5, 2026 Concert's policy...

FocalTherics (FOCL) Surges 6.2%: Is This an Indication of Further Gains?

FocalTherics (FOCL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Alphatec (ATEC) Q2 Earnings Lag Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -22.22% and +1.04%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Lucid Diagnostics to Participate in Upcoming Investor Conferences

Lucid Diagnostics to Participate in Upcoming Investor Conferences Lucid Diagnostics to Participate in Upcoming Investor Conferences PR Newswire NEW YORK, Aug. 4, 2026 NEW YORK, Aug. 4, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.(Nasdaq: LUCD)("Lucid" or the "Company"), a commercial-stage, cancer...

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.

Lucid Diagnostics Inc

PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

LUCDLucid Diagnostics Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest LUCD News